BX-2819
BX-2819 is a Hsp90 inhibitor with an IC50 value of 41 nM. BX-2819 inhibits the proliferation of cancer cells. BX-2819 can significantly inhibit the growth of NCI-N87 and HT-29 tumors in nude mice[1].
Product Specifications
CAS Number
[1184181-50-7]
UNSPSC
12352005
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bx-2819.html
Solubility
10 mM in DMSO
Smiles
CCOC(NCC1=CC=C(C=C1)N2C(NN=C2C3=C(C=C(C(C(C)C)=C3)O)O)=S)=O
Molecular Formula
C21H24N4O4S
Molecular Weight
428.50
References & Citations
[1]Feldman RI, et al. Potent triazolothione inhibitor of heat-shock protein-90. Chem Biol Drug Des. 2009 Jul;74 (1) :43-50.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-157085/BX-2819-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-157085/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HSP70; HSP90
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 3 (LILRB3) Antibody (APC)
Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 3 (LILRB3) Antibody (APC)
Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 3 (LILRB3) Antibody (APC)